Drug-related exanthema under immunotherapy and targeted oncological therapy

Dermatologie (Heidelberg, Germany), 2024 - europepmc.org
Background Oncological therapies can cause a variety of mucocutaneous adverse events.
Exanthematous adverse events can be challenging in the context of the urgent need for …

Drug-related exanthema under immunotherapy and targeted oncological therapy

M Ziemer, E Livingstone - Dermatologie (Heidelberg, Germany) - pubmed.ncbi.nlm.nih.gov
HINTERGRUND: Onkologische Therapien können eine Vielzahl mukokutaner
Nebenwirkungen hervorrufen. Dabei sind es gerade die exanthematischen …